Genetic Diversity, Antimicrobial Resistance Pattern, and Biofilm Formation in Klebsiella pneumoniae Isolated from Patients with Coronavirus Disease 2019 (COVID-19) and Ventilator-Associated Pneumonia

Table 1

Characteristics of patients and K. pneumoniae isolates.

No.	Patients		K. pneumoniae isolates
	Gender	Age (year)	Antimicrobial resistance pattern	MDR	Biofilm formation	ERIC type	Cluster
1	Female	71	Mer, CPM, TOB, AZT, GM, CIP, PTZ	+	No	E28	J
2	Female	50	Mer, CPM, TOB, AZT, IMI, GM, CIP, PTZ	+	No	E28	J
3	Male	56	Mer, CPM, TOB, AZT, IMI, GM, CIP, PTZ	+	No	E28	J
4	Male	78	Mer, CPM, TOB, AZT, IMI, GM, CIP, PTZ	+	No	E28	J
5	Male	59	—	_	No	E21	—
6	Female	69	Mer, CPM, TOB, AZT, GM, CIP, PTZ	+	No	E28	J
7	Female	72	Mer	_	No	E25	H
8	Male	66	Mer, CPM, TOB, AZT, IMI, CIP, PTZ	+	No	E28	J
9	Female	49	Mer, CPM, AZT, CIP, PTZ	+	Moderate	E28	J
10	Female	81	Mer, CPM, TOB, AZT, IMI, GEM, CIP, PTZ	+	No	E28	J
11	Female	75	Mer, CPM, AZT, GM, CIP, PTZ	+	No	E28	J
12	Male	53	Mer, CPM, AZT, IMI, CIP, PTZ	+	Moderate	E14	E
13	Male	52	Mer, CPM, AZT, IMI, GM, CIP, PTZ	+	Weak	E14	E
14	Male	65	Mer, CPM, TOB, AZT, IMI, GM, CIP, PTZ	+	No	E14	E
15	Male	78	Mer, CPM, AZT, IMI, GM, CIP, PTZ	+	Weak	E14	E
16	Male	61	—	_	No	E14	E
17	Male	64	—	_	Moderate	E14	E
18	Female	80	Mer, CPM, AZT, IMI, GM, CIP, PTZ	+	No	E14	E
19	Female	79	Mer, CPM, TOB, AZT, IMI, GM, CIP, PTZ	+	No	E14	E
20	Male	73	—	_	Moderate	E14	E
21	Female	63	Mer, CPM	_	Moderate	E11	—
22	Female	46	Mer, CPM, AZT, IMI, CIP, PTZ	+	No	E15	—
23	Female	55	—	_	Moderate	E14	E
24	Male	58	—	_	Moderate	E5	—
25	Female	61	—	_	Moderate	E13	D
26	Male	51	Mer, CPM, TOB, AZT, IMI, GM, CIP, PTZ	+	No	E10	B
27	Male	76	Mer, CPM, TOB, AZT, IMI, GM, CIP, PTZ	+	No	E10	B
28	Male	79	Mer	_	Moderate	E10	B
29	Female	67	Mer, CPM, TOB, AZT, GM, PTZ	+	No	E10	B
30	Female	58	CPM, TOB, AZT, GM, CIP	+	No	E9	—
31	Female	59	TOB, CIP, PTZ	+	No	E8	A
32	Male	80	Mer, CPM, TOB, AZT, IMI, GM, CIP, PTZ	+	No	E23	—
33	Male	77	Mer, CPM, TOB, AZT, GM, CIP	+	No	E24	G
34	Male	49	Mer, CPM, TOB, AZT, IMI, GM, CIP, PTZ	+	Moderate	E24	G
35	Male	52	Mer, CPM, TOB, AZT, IMI, GM, CIP, PTZ	+	Strong	E24	G
36	Male	54	Mer, CPM, TOB, AZT, IMI, GM, CIP, PTZ	+	Moderate	E24	G
37	Male	73	Mer, CPM, TOB, AZT, IMI, GM, CIP, PTZ	+	No	E22	—
38	Male	67	Mer, CPM, TOB, AZT, GM, CIP, PTZ	+	Moderate	E1	—
39	Male	61	Mer, CPM, AZT, IMI, CIP, PTZ	+	Moderate	E18	F
40	Female	73	Mer	_	Weak	E18	F
41	Female	70	Mer	_	Moderate	E18	F
42	Female	84	PTZ	_	Weak	E16	—
43	Male	50	Mer, CPM, TOB, AZT, IMI, GM, CIP, PTZ	+	No	E17	—
44	Male	72	Mer, CPM, TOB, AZT, IMI, GM, CIP, PTZ	+	Moderate	E28	J
45	Female	74	Mer, TOB, GM, CIP	+	No	E28	J
46	Male	60	Mer, CPM, TOB, AZT, IMI, GM, CIP, PTZ	+	Moderate	E19	—
47	Female	64	Mer, CPM, TOB, AZT, IMI, GM, CIP, PTZ	+	Moderate	E27	I
48	Male	56	Mer, CPM, TOB, AZT, IMI, GM, CIP, PTZ	+	Moderate	E27	I
49	Male	55	Mer, CPM, AZT, IMI, GM, CIP, PTZ	+	No	E27	I
50	Male	71	Mer, TOB	_	Moderate	E26	—
51	Female	77	Mer, CPM, TOB, AZT, IMI, GM, CIP, PTZ	+	No	E25	H
52	Female	83	Mer, CPM, AZT, IMI, GM, CIP, PTZ	+	No	E25	H
53	Female	48	CPM, AZT, CIP, PTZ	+	No	E8	A
54	Female	74	Mer, CPM, TOB, IMI, CIP, PTZ	+	No	E25	H
55	Male	66	Mer, TOB, CIP	+	Moderate	E25	H
56	Male	58	Mer, CPM, TOB, AZT, CIP, PTZ	+	Weak	E7	—
57	Female	68	Mer, TOB, CIP	+	No	E25	H
58	Female	69	Mer, CPM, TOB, AZT, IMI, GM, CIP, PTZ	+	No	E25	H
59	Male	84	Mer, CPM, TOB, AZT, GM, CIP	+	Moderate	E20	—
60	Female	79	CPM, AZT	_	No	E25	H
61	Male	70	Mer, CPM, AZT, CIP, PTZ	+	No	E25	H
62	Male	63	Mer, TOB, AZT, IMI, GM, CIP, PTZ	+	No	E25	H
63	Female	67	Mer, TOB, CIP, PTZ	+	No	E27	I
64	Female	81	Mer, CPM, TOB, AZT, PTZ	+	Strong	E4	—
65	Male	48	Mer, TOB, AZT, IMI, CIP, PTZ	+	Weak	E2	—
66	Male	62	Mer, CPM, TOB, AZT, IMI, GM, CIP, PTZ	+	No	E12	C
67	Male	79	Mer, CPM, TOB, AZT, GM, CIP, PTZ	+	No	E3	—
68	Female	73	Mer, CPM, TOB, AZT, IMI, GM, CIP, PTZ	+	No	E12	C
69	Female	71	Mer, CPM, AZT, IMI, GM, CIP, PTZ	+	No	E13	D
70	Female	65	TOB, CIP	_	Moderate	E6	—